Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Gaulard, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 115 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Demeure, CE; Wolfers, J; Martin-Garcia, N; Gaulard, P; Triebel, F
      T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts

      EUROPEAN JOURNAL OF CANCER
    2. Agrawal, SG; Marquet, J; Plumas, J; Rouard, H; Delfau-Larue, MH; Gaulard, P; Boumsell, L; Reyes, F; Bensussan, A; Farcet, JP
      Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue

      INTERNATIONAL IMMUNOLOGY
    3. Allory, Y; Challine, D; Haioun, C; Copie-Bergman, C; Delfau-Larue, MH; Boucher, E; Charlotte, F; Fabre, M; Michel, M; Gaulard, P
      Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation - A clinicopathologic study of 11 patients in a western institution

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    4. Cazals-Hatem, D; Andre, M; Mounier, N; Copin, MC; Divine, M; Berger, F; Bosly, A; Kerneis, Y; Briere, J; Quesnel, B; Diebold, J; Gaulard, P
      Pathologic and clinical features of 77 Hodgkin's lymphoma patients treatedin a lymphoma protocol (LNH87) - A GELA study

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    5. Petit, B; Leroy, K; Kanavaros, P; Boulland, ML; Druet-Cabanac, M; Haioun, C; Bordessoule, D; Gaulard, P
      Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations

      HUMAN PATHOLOGY
    6. Rahmouni, A; Divine, M; Lepage, E; Jazaerli, N; Belhadj, K; Gaulard, P; Golli, M; Reyes, F; Vasile, N
      Mediastinal lymphoma: Quantitative changes in gadolinium enhancement at MRimaging after treatment

      RADIOLOGY
    7. Brauninger, A; Spieker, T; Willenbrock, K; Gaulard, P; Wacker, HH; Rajewsky, K; Hansmann, ML; Kuppers, R
      Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic Tcell lymphoma

      JOURNAL OF EXPERIMENTAL MEDICINE
    8. Tordjman, R; Delaire, S; Plouet, J; Ting, S; Gaulard, P; Fichelson, S; Romeo, PH; Lemarchandel, V
      Erythroblasts are a source of angiogenic factors

      BLOOD
    9. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
      ALK is not expressed in Hodgkin disease

      BLOOD
    10. Lechapt-Zalcman, E; Challine, D; Delfau-Larue, MH; Haioun, C; Desvaux, D; Gaulard, P
      Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    11. Kanavaros, P; Boulland, ML; Petit, B; Arnulf, B; Gaulard, P
      Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: Association with extranodal site, NK or T gamma delta phenotype, anaplastic morphology and CD30 expression

      LEUKEMIA & LYMPHOMA
    12. Stamatoullas, A; Buchonnet, G; Lepretre, S; Lenain, P; Lenormand, S; Duval, C; Callat, MP; Gaulard, P; Bastard, C; Tilly, H
      De novo acute B cell leukemia/lymphoma with t(14;18)

      LEUKEMIA
    13. Haioun, C; Lepage, E; Gisselbrecht, C; Salles, G; Coiffier, B; Brice, P; Bosly, A; Morel, P; Nouvel, C; Tilly, H; Lederlin, P; Sebban, C; Briere, J; Gaulard, P; Reyes, F
      Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study

      JOURNAL OF CLINICAL ONCOLOGY
    14. Charton-Bain, MC; Brousset, P; Bouabdallah, R; Gaulard, P; Merlio, JP; Dubus, P; Rostaing, L; de Roux, C; Weiller, PJ; Hassoun, J; Xerri, L
      Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma

      HISTOPATHOLOGY
    15. Boulland, ML; Wechsler, J; Bagot, M; Pulford, K; Kanavaros, P; Gaulard, P
      Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins

      HISTOPATHOLOGY
    16. Meignin, V; Briere, J; Brice, P; Gisselbrecht, C; Gaulard, P; Janin, A
      Lymphocytic predominant Hodgkin's disease or type I Hodgkin's disease (paragranuloma of Poppema-Lennert): a clinicopathological entity. Study of 21 cases and review of the literature

      ANNALES DE PATHOLOGIE
    17. Zompi, S; Tulliez, M; Conti, F; Leblond, V; Gaulard, P; Blanche, P; Durand, F; Ghandi, D; Dreyfus, F; Louvel, A; Calmus, Y; Bouscary, D
      Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

      JOURNAL OF HEPATOLOGY
    18. Suarez, F; Wlodarska, I; Rigal-Huguet, F; Mempel, M; Martin-Garcia, N; Farcet, JP; Delsol, G; Gaulard, P
      Hepatosplenic alpha beta T-cell lymphoma - An unusual case with clinical, histologic, and cytogenetic features of gamma delta hepatosplenic T-cell lymphoma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    19. Blakolmer, K; Gaulard, P; Mannhalter, C; Swerdlow, S; Fassati, LR; Rossi, G; Maggi, U; Conte, D; Demetris, AJ
      Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft

      TRANSPLANTATION
    20. Dierlamm, J; Baens, M; Stefanova-Ouzounova, M; Hinz, K; Wlodarska, I; Maes, B; Steyls, A; Driessen, A; Verhoef, G; Gaulard, P; Hagemeijer, A; Hossfeld, DK; De Wof-Peeters, C; Marynen, P
      Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes

      BLOOD
    21. Adida, C; Haioun, C; Gaulard, P; Lepage, E; Morel, P; Briere, J; Dombret, H; Reyes, F; Diebold, J; Gisselbrecht, C; Salles, G; Altieri, DC; Molina, TJ
      Prognostic significance of survivin expression in diffuse large B-cell lymphomas

      BLOOD
    22. Hezode, C; Duvoux, C; Germanidis, G; Roudot-Thoraval, F; Vincens, AL; Gaulard, P; Cherqui, D; Pawlotsky, JM; Dhumeaux, D
      Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation

      HEPATOLOGY
    23. Kanavaros, P; Vlychou, M; Stefanaki, K; Rontogianni, D; Gaulard, P; Pantelidaki, E; Zois, M; Darivianaki, K; Georgoulias, V; Boulland, ML; Gorgoulis, V; Kittas, C
      Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease

      ANTICANCER RESEARCH
    24. Bouron, D; Leger-Ravet, MB; Gaulard, P; Franco, D; Capron, F
      Unusual hepatic neoplasm - B-cell lymphoma (of the polymorphous centroblastic type according to the Kiel classification) developed on a low-grade primary hepatic lymphoma of the malt variety

      ANNALES DE PATHOLOGIE
    25. Conti, F; Calmus, Y; Rouer, E; Gaulard, P; Louvel, A; Houssin, D; Zafrani, ES
      Increased expression of interleukin-4 during liver allograft rejection

      JOURNAL OF HEPATOLOGY
    26. Petrella, T; Dalac, S; Maynadie, M; Mugneret, F; Thomine, E; Courville, P; Joly, P; Lenormand, B; Arnould, L; Wechsler, J; Bagot, M; Rieux, C; Bosq, J; Avril, MF; Bernheim, A; Molina, T; Devidas, A; Delfau-Larue, MH; Gaulard, P; Lambert, D
      CD4+ CD56+ cutaneous neoplasms: A distinct hematological entity?

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    27. Christov, C; Adle-Biassette, H; Lechapt, E; Poron, F; Gray, F; Gaulard, P; Gherardi, RK
      Primary brain lymphoma cell turnover differs in patients with and without AIDS: Relationships to bcl-2 expression and host cell reaction

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    28. Dhedin, N; Giraudier, S; Gaulard, P; Esperou, H; Ifrah, N; Michallet, M; Milpied, N; Rio, B; Cahn, JY; Molina, L; Laporte, JL; Guilhot, F; Kuentz, M
      Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

      BRITISH JOURNAL OF HAEMATOLOGY
    29. Copie-Bergman, R; Gaulard, P; Maouche-Chretien, L; Briere, J; Haioun, C; Alonso, MA; Romeo, PH; Leroy, K
      The MAL gene is expressed in primary mediastinal large B-cell lymphoma

      BLOOD
    30. Germanidis, G; Haioun, C; Pourquier, J; Gaulard, P; Pawlotsky, JM; Dhumeaux, D; Reyes, F
      Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center

      BLOOD
    31. Belec, L; Mohamed, AS; Authier, FJ; Hallouin, MC; Soe, AM; Cotigny, S; Gaulard, P; Gherardi, RK
      Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease

      BLOOD
    32. MAOUCHECHRETIEN L; DELEU N; BADOUAL C; FRAISSIGNES P; BERGER R; GAULARD P; ROMEO PH; LEROYVIARD K
      IDENTIFICATION OF A NOVEL CDNA, ENCODING A CYTOSKELETAL-ASSOCIATED PROTEIN, DIFFERENTIALLY EXPRESSED IN DIFFUSE LARGE B-CELL LYMPHOMAS

      Oncogene
    33. CAMPO E; GAULARD P; ZUCCA E; JAFFE ES; HARRIS NL; DIEBOLD J; SCHLEGELBERGER B; FELLER AC; DELSOL C; GISSELBRECHT C; MONTSERRAT E
      REPORT OF THE EUROPEAN TASK-FORCE ON LYMPHOMAS - WORKSHOP ON PERIPHERAL T-CELL LYMPHOMAS

      Annals of oncology
    34. HAIOUN C; LEPAGE E; GISSELBRECHT C; COIFFIER B; DOYEN C; MOREL P; ATTAL M; TILLY H; DECONINCK E; GAULARD P; REYES F
      HIGH-DOSE THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN PARTIAL-RESPONSE AFTER FIRST-LINE INDUCTION THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Annals of oncology
    35. LAVERGNE A; BROCHERIOU I; DELFAU MH; COPIEBERGMAN C; HOUDART R; GAULARD P
      PRIMARY INTESTINAL GAMMA-DELTA T-CELL LYMPHOMA WITH EVIDENCE OF EPSTEIN-BARR-VIRUS

      Histopathology
    36. SIMON D; HAIOUN C; GAULARD P; SALLES G; TILLY H; BOSLY A; DIEBOLD J; GISSELBRECHT C
      AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PTCL

      Bone marrow transplantation
    37. HAIOUN C; LEPAGE E; GISSELBRECHT C; COIFFIER B; DOYEN C; MOREL P; ARTAL M; TILLY H; DECONINCK E; GAULARD P; REYES F
      AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 94 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL

      Bone marrow transplantation
    38. KANAVAROS P; GAULARD P
      T-CELL AND NATURAL-KILLER-CELL LYMPHOMA - HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ASPECTS

      Annales de pathologie
    39. KAFE H; WECHSLER J; GAULARD P; GOSSELIN B
      EPSTEIN-BARR-VIRUS - PATHOLOGICAL IMPLICA TIONS

      Annales de pathologie
    40. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      Transplantation
    41. BELEC L; HALLOUIN MC; AUTHIER FJ; CREANGE A; GAULARD P; GHERARDI RK
      HUMAN-HERPESVIRUS-8 DNA-SEQUENCES WITH RESTRICTED VARIABILITY IN ORF26 IN PATIENTS WITH POEMS SYNDROME-ASSOCIATED CASTLEMANS-DISEASE

      Neurology
    42. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      British Journal of Haematology
    43. GISSELBRECHT C; GAULARD P; LEPAGE E; COIFFIER B; BRIERE J; HAIOUN C; CAZALSHATEM D; BOSLY A; XERRI L; TILLY H; BERGER F; BOUHABDALLAH R; DIEBOLD J
      PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS

      Blood
    44. ARNULF B; COPIEBERGMAN C; DELFAULARUE MH; LAVERGNESLOVE A; BOSQ J; WECHSLER J; WASSEF M; MATUCHANSKY C; EPARDEAU B; STERN M; BAGOT M; REYES F; GAULARD P
      NONHEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A SUBSET OF CYTOTOXIC LYMPHOMAS WITH MUCOSAL OR SKIN LOCALIZATION

      Blood
    45. WECHSLER J; WILLEMZE R; VANDERBRULE A; THOMINE E; JOLY P; VEROLA O; FONCK Y; SOUTEYRAND P; DELFAU MH; BAGOT M; GAULARD P
      DIFFERENCES IN EPSTEIN-BARR-VIRUS EXPRESSION BETWEEN PRIMARY AND SECONDARY CUTANEOUS ANGIOCENTRIC LYMPHOMAS

      Archives of dermatology
    46. BOULLAND ML; MEIGNIN V; LEROYVIARD K; COPIEBERGMAN C; BRIERE J; TOUITOU R; KANAVAROS P; GAULARD P
      HUMAN INTERLEUKIN-10 EXPRESSION IN T-NATURAL-KILLER-CELL LYMPHOMAS - ASSOCIATION WITH ANAPLASTIC LARGE-CELL LYMPHOMAS AND NASAL NATURAL-KILLER-CELL LYMPHOMAS

      The American journal of pathology
    47. BILLARD C; CAPUT D; VITA N; FERRARA P; ORRICO M; GAULARD P; BOUMSELL L; BENSUSSAN A; FARCET JP
      INTERLEUKIN-13 RESPONSIVENESS AND INTERLEUKIN-13 RECEPTOR EXPRESSION IN NON-HODGKINS-LYMPHOMA AND REACTIVE LYMPH-NODE B-CELLS - MODULATION BY CD40 ACTIVATION

      European cytokine network
    48. LEFREREBELDA MA; MARTIN N; GAULARD P; ZAFRANI ES
      DONOR OR RECIPIENT ORIGIN OF POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS - EVALUATION BY IN-SITU HYBRIDIZATION

      Modern pathology
    49. WENDUM D; SEBBAN C; GAULARD P; COIFFIER B; TILLY H; CAZALS D; BOEHN A; CASASNOVAS RO; BOUABDALLAH R; JAUBERT J; FERRANT A; DIEBOLD J; DEMASCAREL A; GISSELBRECHT C
      FOLLICULAR LARGE-CELL LYMPHOMA TREATED WITH INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL AND COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA

      Journal of clinical oncology
    50. HAIOUN C; LEPAGE E; GISSELBRECHT C; BASTION Y; COIFFIER B; BRICE P; BOSLY A; DUPRIEZ B; NOUVEL C; TILLY H; LEDERLIN P; BIRON P; BRIERE J; GAULARD P; REYES F
      BENEFIT OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION OVER SEQUENTIAL CHEMOTHERAPY IN POOR-RISK AGGRESSIVE NON-HODGKINS-LYMPHOMA - UPDATED RESULTS OF THE PROSPECTIVE-STUDY LNH87-2

      Journal of clinical oncology
    51. BERNIER M; BAGOT M; BROYER M; FARCET JP; GAULARD P; WECHSLER J
      DISTINCTIVE CLINICOPATHOLOGICAL FEATURES ASSOCIATED WITH REGRESSIVE PRIMARY CD30 POSITIVE CUTANEOUS LYMPHOMAS - ANALYSIS OF 6 CASES (VOL 24, PG 157, 1997)

      Journal of cutaneous pathology
    52. BERNIER M; BAGOT M; BROYER M; FARCET JP; GAULARD P; WECHSLER J
      DISTINCTIVE CLINICOPATHOLOGICAL FEATURES ASSOCIATED WITH REGRESSIVE PRIMARY CD30 POSITIVE CUTANEOUS LYMPHOMAS - ANALYSIS OF 6 CASES

      Journal of cutaneous pathology
    53. GAULARD P; BELHADJ K; TILLY H; CHARLOTTE F; LEBLOND V; DUVAL C; ANGONIN R; DECONINCK E; PEROT C; PICO JL; ZAFRANI ES; FARCET JP; REYES F
      REFAIOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - CLINICAL AND BIOLOGICAL CHARACTERISTICS OF A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL

      Experimental hematology
    54. COPIEBERGMAN C; GAULARD P; MAOUCHECHRETIEN L; BOULLAND ML; BRIERE J; HAIOUN C; ROMEO PH; LEROYVIARD K
      OVEREXPRESSION OF MAL MESSENGER-RNA - A NEW MOLECULAR MARKER OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA

      Experimental hematology
    55. LECAM MT; WOLKENSTEIN P; COSNES A; BOCQUET H; GAULARD P; TULLIEZ M; CORDONNIER C; ROUJEAU JC; BAGOT M; REVUZ J
      ACUTE MAST-CELL LEUKEMIA REVEALED BY FLUSH SYNDROME

      Annales de dermatologie et de venereologie
    56. BOULLAND ML; KANAVAROS P; WECHSLER J; CASIRAGHI O; GAULARD P
      CYTOTOXIC PROTEIN EXPRESSION IN NATURAL-KILLER-CELL LYMPHOMAS AND IN ALPHA-BETA AND GAMMA-DELTA PERIPHERAL T-CELL LYMPHOMAS

      Journal of pathology
    57. BOULLAND ML; GAULARD P; DELFAU MH; BAGOT M; WECHSLER J
      CYTOTOXIC PROTEIN EXPRESSION IN CUTANEOUS T-CELL LYMPHOMAS

      Journal of investigative dermatology
    58. TILLY H; GAULARD P; LEPAGE E; DUMONTET C; DIEBOLD J; PLANTIER I; BERGER F; SYMANN M; PETRELLA T; LEDERLIN P; BRIERE J
      PRIMARY ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL PRESENTATION, IMMUNOPHENOTYPE, AND OUTCOME

      Blood
    59. CHEZE S; GAULARD P; COIFFIER B; BOULAT O; BAGLIN AC; BAUMELOU E; RAYMONDGELLE MC; GISSELBRECHT C; DIEBOLD J; LEPORRIER M
      NASAL T-NATURAL-KILLER (NK) CELL LYMPHOMA - CLINICOPATHOLOGICAL STUDYOF 10 CASES FROM THE GELA LNH-87 PROTOCOL

      Blood
    60. HAIOUN C; LEPAGE E; SALLES G; MOREL P; GABARRE J; LEDERLIN P; TILLY H; BOSLY A; GAULARD P; COIFFIER B; GISSELBRECHT C; REYES F
      BONE-MARROW INVOLVEMENT AND LOW SERUM-ALBUMIN LEVEL ARE USEFUL TO BETTER PREDICT SURVIVAL OF POOR-RISK PATIENTS WITH AGGRESSIVE LYMPHOMA ASDEFINED BY THE AGE-ADJUSTED INTERNATIONAL PROGNOSTIC INDEX (AA-IPI)

      Blood
    61. DHEDIN CN; GIRAUDIER S; ESPEROU H; MICHALLET M; IFRAH N; RIO B; CAHN JY; SUTTON L; GAULARD P; KUENTZ M
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGGRESSIVE NON-HODGKIN-LYMPHOMA (EXCEPT LYMPHOBLASTIC AND BURKITT) - A REPORT OF THE FRENCH REGISTRY

      Blood
    62. MOREL P; XERRI L; COJEAN I; GAULARD P; TILLY H; BESUSCHIO S; CASASNOVAS O; DIEBOLD J
      PROGNOSTIC VALUE OF SUBCLASSIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMAS ACCORDING TO THE KIEL CLASSIFICATION - A GELA STUDY ON 1487 PATIENTS

      Blood
    63. REYES F; BELHADJ K; TILLY H; CHARLOTTE F; LEBLOND V; DUVAL C; ANGONIN R; DECONINCK E; TULLIEZ M; PEROT C; PICO JL; ZAFRANI ES; FARCET JP; GAULARD P
      HEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL

      Blood
    64. ARNULF B; COPIEBERGMAN C; DELFAULARUE MH; LAVERGNESLOVE A; BOSQ J; WECHSLER J; WASSEF M; MATUCHANSKY C; EPARDEAU B; STERN M; BAGOT M; REYES F; GAULARD P
      NON HEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A SUBSET OF CYTOTOXICLYMPHOMAS WITH MUCOSAL OR SKIN LOCALIZATION

      Blood
    65. STAMATOULLAS A; BASTARD C; LESESVE JF; LENORMAND B; LENAIN P; LEPRETRE S; FRUCHART C; GAULARD P; TILLY H
      ACUTE B-CELL LEUKEMIA WITH T(14-18)

      Blood
    66. KANAVAROS P; BRIERE J; EMILE JF; GAULARD P
      EPSTEIN-BARR-VIRUS IN T-CELL AND NATURAL-KILLER (NK)-CELL NON-HODGKINS-LYMPHOMAS

      Leukemia
    67. LEPICARD A; HAMMEL P; HAIOUN C; CHAUMETTE MT; GAULARD P; REYES F; DELCHIER JC
      TREATMENT OF LARGE-CELL GASTRIC LYMPHOMA - COMPARATIVE EFFICACY OF RADIOTHERAPY AND CHEMOTHERAPY COMBINATION ALONE OR IN ASSOCIATION WITH GASTRECTOMY

      Gastroenterologie clinique et biologique
    68. CONTI F; LEROYVIARD K; BOULLAND ML; GAULARD P; ZAFRANI ES; HOUSSIN D; CALMUS Y
      SERUM LEVEL AND IN-SITU EXPRESSION OF INTERLEUKIN-10 DURING LIVER ALLOGRAFT-REJECTION IN HUMAN

      Hepatology
    69. OLLIVAUD L; COSNES A; WECHSLER J; GAULARD P; BAGOT M; HAIOUN C; DIVINE M; REVUZ J
      DARIERS SIGN IN CUTANEOUS LARGE T-CELL LYMPHOMA

      Journal of the American Academy of Dermatology
    70. CAZALSHATEM D; LEPAGE E; BRICE P; FERRANT A; DAGAY MF; BAUMELOU E; BRIERE J; BLANC M; GAULARD P; BIRON P; SCHLAIFER D; DIEBOLD J; AUDOUIN J
      PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 141 CASES COMPARED WITH 916 NONMEDIASTINAL LARGE B-CELL LYMPHOMAS, A GELA (GROUPE-DETUDE-DES-LYMPHOMES-DE-LADULTE) STUDY

      The American journal of surgical pathology
    71. EMILE JF; GAULARD P
      CD56 LYMPHOMAS

      The American journal of surgical pathology
    72. PETRELLA T; DELFAULARUE MH; CAILLOT D; MORCILLO JL; CASASNOVAS O; PORTIER H; GAULARD P; FARCET JP; ARNOULD L
      NASOPHARYNGEAL LYMPHOMAS - FURTHER EVIDENCE FOR A NATURAL-KILLER-CELLORIGIN

      Human pathology
    73. KANAVAROS P; BRIERE J; LESCS MC; GAULARD P
      EPSTEIN-BARR-VIRUS IN NON-HODGKINS-LYMPHOMAS OF THE UPPER RESPIRATORY-TRACT - ASSOCIATION WITH SINONASAL LOCALIZATION AND EXPRESSION OF NK AND OR T-CELL ANTIGENS BY TUMOR-CELLS/

      Journal of pathology
    74. THEODOROU I; BIGORGNE C; DELFAU MH; LAHET C; COCHET G; VIDAUD M; RAPHAEL M; GAULARD P; FARCET JP
      VJ REARRANGEMENTS OF THE TCR-GAMMA LOCUS IN PERIPHERAL T-CELL LYMPHOMAS - ANALYSIS BY POLYMERASE CHAIN-REACTION AND DENATURING GRADIENT GEL-ELECTROPHORESIS

      Journal of pathology
    75. BAGOT M; CHARUE D; BOULLAND ML; GAULARD P; REVUZ J; SCHMITT C; WECHSLER J
      INTERLEUKIN-7 RECEPTOR EXPRESSION IN CUTANEOUS T-CELL LYMPHOMAS

      British journal of dermatology
    76. GISSELBRECHT C; GAULARD P; LEPAGE E; COIFFIER B; BRIERE FJ; HAIOUN C; CAZALS D; BOSLY A; XERRI L; TILLY H; BERGER F; BOUHABDALLAH R; DIEBOLD J
      PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS

      Blood
    77. DETOURMIGNIES L; COPIN MC; MOREL P; VANRUMBEKE M; PREUDHOMME C; WATTEL E; GAULARD P; GISSELBRECHT C; GOSSELIN B; FENAUX P
      P53 OVEREXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMA (DLCL) AND ITS PROGNOSTIC VALUE BY MULTIPARAMETER ANALYSIS

      Blood
    78. EMILE JF; BOULLAND ML; HAIOUN C; KANAVAROS P; PETRELLA T; DELFAULARUE MH; BENSUSSAN A; FARCET JP; GAULARD P
      CD5(-) CD56(-CELL RECEPTOR SILENT PERIPHERAL T-CELL LYMPHOMAS ARE NATURAL-KILLER-CELL LYMPHOMAS() T)

      Blood
    79. HERMINE O; HAIOUN C; LEPAGE E; DAGAY MF; BRIERE J; LAVIGNAC C; FILLET G; SALLES G; MAROLLEAU JP; DIEBOLD J; REYES F; GAULARD P
      PROGNOSTIC-SIGNIFICANCE OF BCL-2 PROTEIN EXPRESSION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA

      Blood
    80. KANAVAROS P; DEBRUIN PC; BRIERE J; MEIJER CJLM; GAULARD P
      EPSTEIN-BARR-VIRUS (EBV) IN EXTRANODAL T-CELL NON-HODGKINS-LYMPHOMAS (T-NHL) - IDENTIFICATION OF NASAL T-NHL AS A DISTINCT CLINICOPATHOLOGICAL ENTITY ASSOCIATED WITH EBV

      Leukemia & lymphoma
    81. HAMMEL P; HAIOUN C; CHAUMETTE MT; GAULARD P; DIVINE M; REYES F; DELCHIER JC
      EFFICACY OF SINGLE-AGENT CHEMOTHERAPY IN LOW-GRADE B-CELL MUCOSA-ASSOCIATED LYMPHOID-TISSUE LYMPHOMA WITH PROMINENT GASTRIC EXPRESSION

      Journal of clinical oncology
    82. EMILE JF; WECHSLER J; BROUSSE N; BOULLAND ML; COLOGON R; FRAITAG S; VOISIN MC; GAULARD P; BOUMSELL L; ZAFRANI ES
      LANGERHANS CELL HISTIOCYTOSIS - DEFINITIVE DIAGNOSIS WITH THE USE OF MONOCLONAL-ANTIBODY-O10 ON ROUTINELY PARAFFIN-EMBEDDED SAMPLES

      The American journal of surgical pathology
    83. WECHSLER J; CHARUE D; BOULLAND ML; GAULARD P; SCHMITT C; BAGOT M
      INTERLEUKIN-7 RECEPTOR EXPRESSION IN CUTANEOUS T-CELL LYMPHOMAS

      Journal of investigative dermatology
    84. NAVRATIL E; GAULARD P; KANAVAROS P; AUDOUIN J; BOUGARAN J; MARTIN N; DIEBOLD J; MASON DY
      EXPRESSION OF THE BCL-2 PROTEIN IN B-CELL LYMPHOMAS ARISING FROM MUCOSA-ASSOCIATED LYMPHOID-TISSUE

      Journal of Clinical Pathology
    85. HAMMEL P; HAIOUN C; CHAUMETTE MT; DIVINE M; GAULARD P; REYES F; DELCHIER JC
      MONOCHEMOTHERAPY AS TREATMENT OF LOW-GRADE B-CELL GASTRIC-MUCOSA ASSOCIATED LYMPHOID-TISSUE LYMPHOMA

      Gastroenterology
    86. LEPICARD A; HAMMEL P; CHAUMETTE MT; HAIOUN C; DIVINE M; GAULARD P; REYES F; DELCHIER JC
      CONSERVATIVE TREATMENT IS SUITABLE IN PATIENTS WITH HIGH-GRADE GASTRIC LYMPHOMA

      Gastroenterology
    87. HAIOUN C; LEPAGE E; GISSELBRECHT C; BASTION Y; DOYEN C; PLANTIER I; SCHLAIFER D; TILLY H; DECONINCK E; BORDESSOULE D; GAULARD P; REYES F
      AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 96 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL

      Blood
    88. EMILE JF; BOULLAND ML; HAIOUN C; KANAVAROS P; PETRELLA T; DELFAULARUE MH; BENSUSSAN A; FARCET JP; GAULARD P
      CD5- CD56-CELL LYMPHOMAS ARE NATURAL-KILLER-CELL LYMPHOMAS( TCR SILENT PERIPHERAL T)

      Blood
    89. SEBBAN C; WENDUM D; GAULARD P; COIFFIER B; CAZALS D; GABARRE J; CASANOVAS O; BOUABDALLAH R; JAUBERT J; FILLET G; DIEBOLD J; GISSELBRECHT C
      FOLLICULAR LARGE-CELL LYMPHOMA (FLCL) TREATED BY INTENSIVE CHEMOTHERAPY - AN ANALYSIS OF 89 CASES INCLUDED IN THE LNH87 TRIAL END COMPARISON WITH THE OUTCOME OF DIFFUSE LARGE-CELL LYMPHOMA (DLCL)

      Blood
    90. HAIOUN C; LEPAGE E; GISSELBRECHT C; COIFFIER B; BOSLY A; DUPRIEZ B; NOUVEL C; TILLY H; LEDERLIN P; BIRON P; BRIERE J; GAULARD P; REVES F
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VERSUS SEQUENTIAL CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) IN FIRST COMPLETE REMISSION (CR) - A STUDY OF 542 PATIENTS (LNH87-2 PROTOCOL)

      Blood
    91. LEVY Y; MANSUR IG; DELFAU MH; ORRICO M; GAULARD P; BOUMSELL L; FARCET JP; BENSUSSAN A
      SELECTIVE LYSIS OF AUTOLOGOUS B-LYMPHOMA-CELLS BY TCR-ALPHA-BETA(-INFILTRATING T-LYMPHOCYTES() CELLS DERIVED FROM TUMOR)

      Blood
    92. CHEVALIER X; HERMINE O; AUTHIER FJ; GAULARD P; GHERARDI RK
      CARPAL-TUNNEL SYNDROME DUE TO T-CELL LYMPHOMA

      Arthritis and rheumatism
    93. WECHSLER J; BAGOT M; HENNI T; LECOUEDIC JP; GAULARD P; ZAFRANI ES
      GENE ANALYSIS IN 18 CASES OF CUTANEOUS LYMPHOID INFILTRATES OF UNCERTAIN SIGNIFICANCE

      Archives of pathology and laboratory medicine
    94. KANAVAROS P; GAULARD P; CHARLOTTE F; MARTIN N; DUCOS C; LEBEZU M; MASON DY
      DISCORDANT EXPRESSION OF IMMUNOGLOBULIN AND ITS ASSOCIATED MOLECULE MB-1 CD79A IS FREQUENTLY FOUND IN MEDIASTINAL LARGE B-CELL LYMPHOMAS/

      The American journal of pathology
    95. HAIOUN C; LEPAGE E; GISSELBRECHT C; COIFFIER B; BOSLY A; TILLY H; MOREL P; NOUVEL C; HERBRECHT R; DAGAY MF; GAULARD P; REYES F
      COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH SEQUENTIAL CHEMOTHERAPY FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA IN FIRST COMPLETE REMISSION - A STUDY OF 464 PATIENTS

      Journal of clinical oncology
    96. HUARD B; GAULARD P; FAURE F; HERCEND T; TRIEBEL F
      CELLULAR EXPRESSION AND TISSUE DISTRIBUTION OF THE HUMAN LAG-3-ENCODED PROTEIN, AN MHC CLASS-II LIGAND

      Immunogenetics
    97. THEODOROU I; RAPHAEL M; BIGORGNE C; FOURCADE C; LAHET C; COCHET G; LEFRANC MP; GAULARD P; FARCET JP
      RECOMBINATION PATTERN OF THE TCR GAMMA-LOCUS IN HUMAN PERIPHERAL T-CELL LYMPHOMAS

      Journal of pathology
    98. WECHSLER J; CHARUE D; BOULLAND ML; GAULARD P; SCHMITT C; BAGOT M
      INTERLEUKIN-7 RECEPTOR EXPRESSION IN CUTANEOUS T-CELL LYMPHOMAS

      Journal of investigative dermatology
    99. HAMMEL P; HAIOUN C; CHAUMETTE MT; GAULARD P; BLASQUEZ M; TULLIEZ M; DREYFUS F; CHAUSSADE S; REYES F; DELCHIER JC
      EFFICACY OF MONOCHEMOTHERAPY IN PATIENTS WITH LOW-GRADE B-CELL MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) LYMPHOMA OF THE STOMACH

      Gastroenterology
    100. GHERARDI RK; BELEC L; FROMONT G; DIVINE M; MALAPERT D; GAULARD P; DEGOS JD
      ELEVATED LEVELS OF INTERLEUKIN-1-BETA (IL-1-BETA) AND IL-6 IN SERUM AND INCREASED PRODUCTION OF IL-1-BETA MESSENGER-RNA IN LYMPH-NODES OF PATIENTS WITH POLYNEUROPATHY, ORGANOMEGALY, ENDOCRINOPATHY, M-PROTEIN, AND SKIN CHANGES (POEMS) SYNDROME

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 19:55:00